Educational Video for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast Cancer+3 MoreEducational Video - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether two different ways of providing information to people considering genetic testing for cancer risk affects how likely they are to get the test.

Eligible Conditions
  • Breast Cancer
  • Ovarian Cancer
  • Hormone-Refractory Prostate Cancer
  • Pancreatic Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: Up to 3 years

Immediately following intervention
Knowledge about genetics testing
Patient Satisfaction Survey following intervention
Result Disclosure Preference following intervention
Up to 3 years
Rate of patients who have germline genetic tests
after results have been received, four months post-intervention
Cascade testing in positives
Positive Results impact
after results have been received, two months post-intervention
Decisional Regret
Family communication of genetic test results
Interventional procedure
Psychological distress following intervention

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Group A: Standard genetic counseling
1 of 2
Group B: Educational video
1 of 2

Active Control

Experimental Treatment

220 Total Participants · 2 Treatment Groups

Primary Treatment: Educational Video · No Placebo Group · N/A

Group B: Educational video
Behavioral
Experimental Group · 1 Intervention: Educational Video · Intervention Types: Behavioral
Group A: Standard genetic counseling
Behavioral
ActiveComparator Group · 1 Intervention: Standard Genetic Counseling · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Video
2013
N/A
~660

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 years

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,016 Previous Clinical Trials
393,578 Total Patients Enrolled
134 Trials studying Breast Cancer
21,448 Patients Enrolled for Breast Cancer
Ambry GeneticsIndustry Sponsor
3 Previous Clinical Trials
485 Total Patients Enrolled
Huma Rana, MD5.05 ReviewsPrincipal Investigator - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
5Patient Review
Dr. Rana is an excellent caretaker, especially for those with a genetic disposition for cancer. She is very knowledgeable and takes her time with each patient to ensure they feel comfortable and confident.

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Potentially eligible participants will be identified from their medical records, or from their clinical visits if they are already patients at the enrolling Institution
is needed No prior cancer genetic testing is necessary.
are the two essential ingredients for any research study
Cancers that originate in the breast, ovaries, pancreas, or metastatic prostate cancer.